BENEFIT OF A LOCAL HEPATITIS B REACTIVATION GUIDELINE TO IMPROVE SCREENING AND PROPHYLAXIS FOR PATIENTS INITIATED ON RITUXIMAB

被引：0
|
作者：
Boothman, Helen [1 ]
Jadawji, Zainab [1 ]
Hesketh, Hannah [1 ]
Reynolds, Kieran [1 ]
Clark, Sarah [1 ]
机构：
[1] St George Hosp, London, England
来源：
GUT | 2023年 / 72卷 / SUPPL_3期
关键词：
D O I：
10.1136/gutjnl-2023-BASL.138
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P124
引用
收藏
页码：A95 / A96
页数：2
相关论文
共 50 条
  • [1] BENEFIT OF A LOCAL HEPATITIS B REACTIVATION GUIDELINE TO IMPROVE SCREENING AND PROPHYLAXIS FOR PATIENTS INITIATED ON RITUXIMAB
    Boothman, Helen
    Jadawji, Zainab
    Hesketh, Hannah
    Reynolds, Kieran
    Clark, Sarah
    GUT, 2023, 72 : A95 - A96
  • [2] The benefit of a local hepatitis B reactivation guideline to improve screening and prophylaxis for patients initiated on rituximab
    Boothman, Helen
    Reynolds, Kieran
    Jadawdji, Zainab
    Hesketh, Hannah
    Clark, Sarah
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1129 - S1129
  • [3] Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab
    Buensalido, Joseph Adrian Lumawig
    Chandrasekar, Pranatharthi H.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (02) : 151 - 154
  • [4] Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab
    Hamaki, T
    Kami, M
    Kusumi, E
    Ueyama, J
    Miyakoshi, S
    Morinaga, S
    Mutou, Y
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (04) : 292 - 294
  • [5] Screening and Prophylaxis to Prevent Hepatitis B Reactivation Transplant Recipients
    Sasadeusz, Joe
    Grigg, Andrew
    Hughes, Peter D.
    Lim, Seng Lee
    Lucas, Michaela
    McColl, Geoff
    McLachlan, Sue Anne
    Peters, Marion G.
    Shackel, Nicholas
    Slavin, Monica
    Sundararajan, Vijaya
    Thompson, Alexander
    Doyle, Joseph
    Rickard, James
    De Cruz, Peter
    Gish, Robert G.
    Visvanathan, Kumar
    CLINICS IN LIVER DISEASE, 2019, 23 (03) : 493 - +
  • [6] Screening and Prophylaxis to Prevent Hepatitis B Reactivation Introduction and Immunology
    Sasadeusz, Joe
    Grigg, Andrew
    Hughes, Peter D.
    Lim, Seng Lee
    Lucas, Michaela
    McColl, Geoff
    McLachlan, Sue Anne
    Peters, Marion G.
    Shackel, Nicholas
    Slavin, Monica
    Sundararajan, Vijaya
    Thompson, Alexander
    Doyle, Joseph
    Rickard, James
    De Cruz, Peter
    Gish, Robert G.
    Visvanathan, Kumar
    CLINICS IN LIVER DISEASE, 2019, 23 (03) : 487 - +
  • [7] Screening and Prophylaxis to Prevent Hepatitis B Reactivation Patients with Hematological and Solid Tumor Malignancies
    Sasadeusz, Joe
    Grigg, Andrew
    Hughes, Peter D.
    Lim, Seng Lee
    Lucas, Michaela
    McColl, Geoff
    McLachlan, Sue Anne
    Peters, Marion G.
    Shackel, Nicholas
    Slavin, Monica
    Sundararajan, Vijaya
    Thompson, Alexander
    Doyle, Joseph
    Rickard, James
    De Cruz, Peter
    Gish, Robert G.
    Visvanathan, Kumar
    CLINICS IN LIVER DISEASE, 2019, 23 (03) : 511 - +
  • [8] Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness
    Hay, Annette E.
    Meyer, Ralph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3155 - 3157
  • [9] Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab
    Pei, Sung-Nan
    Chen, Chien-Hung
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1611 - 1618
  • [10] Prophylaxis and therapy of reactivation of hepatitis B in immunosuppressed patients
    von Wagner, M.
    Zeuzem, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (06) : 255 - 258
12345